StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
OM

Outset Medical, Inc.

OM Nasdaq Electromedical & Electrotherapeutic Apparatus EDGAR ↗
$4.99
+0.24 +5.05%

Key statistics

from XBRL data in SEC filings
Market cap
$92.5M
Revenue (TTM)
$118M
Net income (TTM)
-$74.8M
EPS (TTM)
$-2.74
P/E ratio
Dividend yield
Free cash flow
-$47.1M
Cash
$30.6M
Total assets
$249M
Gross margin
40.6%
52-week range
$3.00 – $17.20

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Entered a material agreement; Results of operations (earnings release) Jun 17, 2026 8-K Shareholder vote results Jun 5, 2026 8-K Director or officer change May 29, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 10-K Fiscal year ended 2025-12-31 Feb 13, 2026 8-K Results of operations (earnings release) Feb 11, 2026 8-K Other events Jan 27, 2026 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Director or officer change; Shareholder vote results; Regulation FD disclosure Jun 3, 2025 8-K Director or officer change; Regulation FD disclosure May 14, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 7, 2025 8-K Modified rights of security holders; Amended charter or bylaws Mar 20, 2025 8-K Other events Mar 18, 2025 8-K Amended charter or bylaws; Other events Mar 11, 2025 8-K Shareholder vote results Mar 6, 2025 10-K Fiscal year ended 2024-12-31 Feb 28, 2025 8-K Delisting notice or listing-rule failure; Other events Feb 26, 2025 8-K Results of operations (earnings release) Feb 19, 2025 8-K Amended charter or bylaws Jan 24, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Amended charter or bylaws Jan 8, 2025 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Regulation FD disclosure Jan 6, 2025 10-Q Quarter ended 2024-09-30 Nov 7, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Delisting notice or listing-rule failure Sep 27, 2024 8-K Director or officer change Aug 16, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Shareholder vote results May 30, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release); Director or officer change; Other events May 8, 2024 8-K Other events May 6, 2024 8-K Director or officer change; Regulation FD disclosure Mar 13, 2024 10-K Fiscal year ended 2023-12-31 Feb 21, 2024 8-K Results of operations (earnings release); Director or officer change Feb 21, 2024